Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemotherapeutic neuropathy.

A J Windebank1

  • 1Mayo Medical Center, Rochester, MN 55905, USA. windebank.anthony@mayo.edu

Current Opinion in Neurology
|December 11, 1999
PubMed
Summary
This summary is machine-generated.

Peripheral neurotoxicity, a common chemotherapy side effect, impacts nerve cells. Understanding its cellular mechanisms is key to developing treatments that protect neurons without reducing drug effectiveness.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechano growth factor interacts with nucleolin to protect against cisplatin-induced neurotoxicity.

Experimental neurology·2020
Same author

Dynamic role of kallikrein 6 in traumatic spinal cord injury.

The European journal of neuroscience·2006
Same author

Melarsoprol-associated multifocal inflammatory CNS illness in African trypanosomiasis.

Neurology·2006
Same author

Animal models of spinal cord injury for evaluation of tissue engineering treatment strategies.

Biomaterials·2003
Same author

Inflammation and neuropathic attacks in hereditary brachial plexus neuropathy.

Journal of neurology, neurosurgery, and psychiatry·2002
Same author

Alterations in cell cycle regulation underlie cisplatin induced apoptosis of dorsal root ganglion neurons in vivo.

Neurobiology of disease·2001
Same journal

Movement disorders and Parkinson's disease: collaborative and interdisciplinary research to advance understanding of neural circuit dysfunction, pathophysiology, and care: new horizons in technology, neuroimaging, neurophysiology, and genetics toward personalized medicine.

Current opinion in neurology·2026
Same journal

Editorial introduction.

Current opinion in neurology·2026
Same journal

Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention.

Current opinion in neurology·2026
Same journal

Tourette syndrome: brain neurophysiology, circuit dysfunction, and neuromodulation across invasive and noninvasive approaches.

Current opinion in neurology·2026
Same journal

Dystonia: from phenotypes to genetics and therapeutic advances.

Current opinion in neurology·2026
Same journal

What can we learn from eye movements in movement disorders and Parkinson's disease?

Current opinion in neurology·2026
See all related articles

Area of Science:

  • Neuroscience
  • Oncology
  • Pharmacology

Background:

  • Peripheral neurotoxicity is a significant dose-limiting side effect of many chemotherapy drugs.
  • Commonly implicated agents include platinum compounds, taxanes, and vinca alkaloids.
  • Emerging chemotherapeutics like suramin and Dolostatin-10 also induce neuropathy.

Purpose of the Study:

  • To explore the cellular mechanisms underlying chemotherapy-induced peripheral neurotoxicity.
  • To identify potential targets for neuroprotective strategies.
  • To inform the development of treatments that mitigate nerve damage without compromising anti-cancer efficacy.

Main Methods:

  • Review of existing literature on chemotherapy-induced neurotoxicity.
  • Analysis of cellular pathways implicated in neuronal damage.

Related Experiment Videos

  • Identification of commonalities and differences in neurotoxic mechanisms across drug classes.

    • Main Results:

    • Chemotherapeutic agents induce peripheral neurotoxicity through various cellular pathways.
    • Platinum compounds, taxanes, and vinca alkaloids exhibit distinct but overlapping mechanisms.
    • Newer agents like suramin and Dolostatin-10 present novel neurotoxic profiles.

    Conclusions:

    • A comprehensive understanding of the cellular basis of neurotoxicity is crucial.
    • Targeting specific cellular mechanisms may offer a way to protect neurons.
    • Future research should focus on developing neuroprotective strategies that preserve therapeutic efficacy.